Biosimilars are biopharmaceutical drugs that are similar to an already approved biological drug, known as reference biologic drug or brand-name biologic. Biosimilars help reduce healthcare costs as they can be priced lower than reference biologics. Biosimilars have large-molecule structures that are similar but not identical to approved biological drugs, exhibiting lesser side effects. The...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian